A phase I/II multiple expansion cohort trial of MRTX849 in patients with advanced solid tumors with KRAS G12C mutation.

被引：29

作者：

Papadopoulos, Kyriakos P.

Ou, Sai-Hong Ignatius

Johnson, Melissa Lynne

Christensen, James

Velastegui, Karen

Potvin, Diane

Faltaos, Demiana

Chao, Richard C.

机构：

[1] South Texas Accelerated Res Therapeut, San Antonio, TX USA

[2] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA

[3] Sarah Cannon Res Inst, Nashville, TN USA

[4] Mirati Therapeut Inc, San Diego, CA USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.TPS3161

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS3161

引用

页数：1